Frank Baldino Jr.

Frank Baldino Jr.' is an American pharmacologist and entrepreneur, best known as the founder and former CEO of Cephalon, a biopharmaceutical company.

Early Life and Education

Frank Baldino Jr. was born in Philadelphia, Pennsylvania. He received his Bachelor's degree in Biology from Rutgers University and his Ph.D. in Pharmacology from the Temple University School of Medicine.

Career

After completing his education, Baldino worked as a senior scientist at DuPont Pharmaceuticals. In 1987, he founded Cephalon, a company focused on the research and development of neurological and sleep disorders. Under his leadership, Cephalon grew into a successful biopharmaceutical company, developing several important drugs including Provigil and Nuvigil.

Baldino was known for his dedication to research and development, and his commitment to bringing innovative therapies to market. He was also recognized for his contributions to the field of neuroscience and was a member of several professional organizations, including the American Society for Pharmacology and Experimental Therapeutics and the Society for Neuroscience.

Death

Baldino passed away in December 2010. His death was a significant loss to the field of pharmacology and the biopharmaceutical industry.

Legacy

Baldino's work continues to have a significant impact on the field of pharmacology. His dedication to research and development has led to the creation of several important drugs, and his leadership at Cephalon has influenced the growth and success of the biopharmaceutical industry.

See Also

• Cephalon
• Pharmacology
• Neuroscience

References

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!